Insider · CIK 0001378435
Christophe Jean
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing -, latest -.
Christophe Jean files SEC Form 4 as director at RYTM (RHYTHM PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christophe Jean has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,712 | - | - | 11,712 | Jun 25, 2026 |
| Jun 23, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,712 | $0.00 | $0 | 0 | Jun 25, 2026 |
| Jun 24, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +3,691 | $0.00 | $0 | 3,691 | Jun 25, 2026 |
| Jun 24, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +2,324 | $0.00 | $0 | 2,324 | Jun 25, 2026 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +7,037 | $0.00 | $0 | 7,037 | Jun 26, 2025 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +4,712 | $0.00 | $0 | 4,712 | Jun 26, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,000 | - | - | 7,000 | Jun 23, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
Questions about Christophe Jean
Answered from the filings on this page, as of the latest one.
Is Christophe Jean buying or selling?
Christophe Jean has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christophe Jean's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christophe Jean has 0.
Where does Christophe Jean file Form 4?
Christophe Jean has filed Form 4 at RYTM (RHYTHM PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.